Page last updated: 2024-12-05

xu 62-320

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

fluvastatin sodium : A racemate that is the sodium salt of fluvastatin. An HMG-CoA reductase inhibitor, it is used to reduce triglycerides and LDL-cholesterol, and increase HDL-chloesterol, in the treatment of hyperlipidaemia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16760425
CHEMBL ID2218894
SCHEMBL ID556763
SCHEMBL ID1786786
MeSH IDM0179297

Synonyms (16)

Synonym
lochol
xu-62-320
canef
fluvastatin sodium
vastin
93957-55-2
fluvastatin sodium salt
CHEMBL2218894
fluvastatin-d8 (major), sodium salt
SCHEMBL556763
ZGGHKIMDNBDHJB-CALJPSDSSA-M
SCHEMBL1786786
AKOS026750119
sodium;(e)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate
BCP12844
6-heptenoic acid,7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1h-indol-2-yl]-3,5-dihydroxy-,monosodium salt, [r*,r*-(e)]-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
3-hydroxy-3-methylglutaryl-coenzyme A reductase Rattus norvegicus (Norway rat)IC50 (µMol)5.31170.00090.20949.0300AID309702; AID80972; AID83469; AID83479
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID227064IC50 ratio evaluated as the IC50 values of testis to that of liver.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID80972Inhibitory activity against partially purified rat liver HMG-CoA reductase in vitro; 0.0015-0.00401993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
AID179216Incorporation of [14C]- acetate into sterols measured in rat spleen.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID406851Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W22007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID406850Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum IMT0312007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID24184Distribution coefficient in octanol/water at pH 6.51998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID81400Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.053-0.121993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
AID21264Effective permeability measured in human.1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID179215Incorporation of [14C]- acetate into sterols measured in rat liver.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID406849Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D72007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID1220876Apparent permeability of the compound in BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1220877Apparent permeability of the compound in MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID406852Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Bre12007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID1220864Apparent permeability from basolateral to apical side of P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID227063IC50 ratio evaluated as the IC50 values of spleen to that of liver.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID1220875Apparent permeability of the compound in P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1220861Apparent permeability from basolateral to apical side of MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID406848Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D62007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID83479In vitro inhibition of solubilized HMG-CoA reductase in rat liver.1991Journal of medicinal chemistry, Oct, Volume: 34, Issue:10
Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
AID15711Calculated partition coefficient (clogP)1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID1220885Apparent permeability from basolateral to apical side of vector transfected human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1220868Apparent permeability from basolateral to apical side of BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID24185Distribution coefficient in octanol/water at pH 7.41998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID15720Calculated partition coefficient (clogP)1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID26400pKa value of the compound. (extrapolated value)1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID179217Incorporation of [14C]- acetate into sterols measured in rat testis.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID18861GOF value represents multisets of log P data1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID24421Partition coefficient (logD)1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID406853Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR32007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
AID309702Inhibition of Holtzman-Sprague-Dawley rat liver HMG CoA reductase after 30 mins2007Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.
AID24420Partition coefficient (logP)1998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
AID1220874Apparent permeability of the compound in vector transfected human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID83469Ability to inhibit microsomal preparation of HMG-CoA reductase in rat liver.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
AID24183Distribution coefficient in octanol/water at pH 5.51998Journal of medicinal chemistry, Dec-03, Volume: 41, Issue:25
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]